Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003469854 | SCV004192408 | likely pathogenic | Bifunctional peroxisomal enzyme deficiency | 2023-04-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003779044 | SCV004605619 | pathogenic | Bifunctional peroxisomal enzyme deficiency; Perrault syndrome | 2023-07-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu247*) in the HSD17B4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HSD17B4 are known to be pathogenic (PMID: 11810648, 16385454, 20673864). This variant is present in population databases (rs144141837, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with HSD17B4-related conditions. For these reasons, this variant has been classified as Pathogenic. |